Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Follow-Up Questions
BRSYF の株価パフォーマンスは？
BRSYF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Brainsway Ltd の主な事業テーマや業界は？
Brainsway Ltd は Health Care 業界、セクターは Health Care に属しています。
